Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
39.21
-0.66 (-1.66%)
Aug 28, 2026, 4:00 PM EDT - Market closed
HRMY Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,283 | 2,155 | 1,962 | 1,892 | 3,268 | 2,493 | |
Market Cap Growth | 4.31% | 9.83% | 3.73% | -42.12% | 31.09% | 21.23% |
Enterprise Value | 1,776 | 1,652 | 1,737 | 1,721 | 3,155 | 2,496 |
Last Close Price | 39.21 | 37.42 | 34.41 | 32.30 | 55.10 | 42.64 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.69 | 13.58 | 13.49 | 14.68 | 18.01 | 72.07 |
Forward PE | 9.79 | 10.05 | 11.82 | 11.14 | 23.01 | 25.27 |
PS Ratio | 2.38 | 2.48 | 2.75 | 3.25 | 7.47 | 8.16 |
PB Ratio | 2.28 | 2.48 | 2.98 | 4.05 | 8.11 | 13.37 |
P/TBV Ratio | 2.48 | 2.76 | 3.60 | 5.74 | 13.51 | 58.54 |
P/FCF Ratio | 6.43 | 6.20 | 8.98 | 8.64 | 22.65 | 25.37 |
P/OCF Ratio | 6.43 | 6.19 | 8.93 | 8.62 | 22.62 | 25.30 |
PEG Ratio | 0.34 | 0.39 | 0.47 | 0.73 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.85 | 1.90 | 2.43 | 2.96 | 7.21 | 8.17 |
EV/EBITDA Ratio | 6.94 | 7.07 | 8.08 | 7.95 | 21.98 | 23.46 |
EV/EBIT Ratio | 7.70 | 7.93 | 9.10 | 8.96 | 26.25 | 28.51 |
EV/FCF Ratio | 5.00 | 4.75 | 7.95 | 7.86 | 21.87 | 25.40 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.16 | 0.19 | 0.28 | 0.42 | 0.48 | 1.05 |
Debt / EBITDA Ratio | 0.62 | 0.72 | 0.84 | 0.90 | 1.34 | 1.82 |
Debt / FCF Ratio | 0.45 | 0.49 | 0.83 | 0.90 | 1.35 | 1.99 |
Net Debt / Equity Ratio | -0.51 | -0.70 | -0.43 | -0.34 | -0.32 | -0.21 |
Net Debt / EBITDA Ratio | -1.98 | -2.59 | -1.33 | -0.73 | -0.90 | -0.36 |
Net Debt / FCF Ratio | -1.43 | -1.74 | -1.31 | -0.72 | -0.89 | -0.39 |
Asset Turnover | 0.77 | 0.77 | 0.79 | 0.78 | 0.79 | 0.71 |
Inventory Turnover | 37.87 | 31.60 | 24.97 | 25.10 | 19.13 | 13.45 |
Quick Ratio | 3.33 | 3.46 | 3.14 | 2.61 | 4.79 | 5.01 |
Current Ratio | 3.48 | 3.60 | 3.31 | 2.75 | 5.07 | 5.29 |
Return on Equity (ROE) | 20.46% | 20.75% | 25.84% | 29.63% | 61.58% | 24.39% |
Return on Assets (ROA) | 11.62% | 11.47% | 13.17% | 16.16% | 13.57% | 12.71% |
Return on Invested Capital (ROIC) | 37.45% | 48.26% | 42.39% | 48.91% | 56.97% | 76.78% |
Return on Capital Employed (ROCE) | 20.30% | 20.40% | 23.20% | 29.60% | 20.20% | 23.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.94% | 7.36% | 7.41% | 6.81% | 5.55% | 1.39% |
FCF Yield | 15.54% | 16.14% | 11.14% | 11.58% | 4.42% | 3.94% |
Buyback Yield / Dilution | -0.65% | -1.17% | 4.15% | 1.19% | -3.19% | -129.72% |